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To the editor: The inclusion of preparation for death and managing affairs in the end 
of life instrument designed by Borreani et al. (1) to elicit preferences about dying is 
commendable. Of note, few quality of life (QOL) measurement tools contain or 
adequately assess this patient-valued domain. Given the importance that patients place 
on these issues, it is possible that evaluations of palliative health care interventions, 
including comparative effectiveness and cost-effectiveness analyses, could easily 
misinterpret the net benefit of such interventions without inclusion of this domain as 
an outcome measure. Better assessment methods that incorporate preparation for 
death and managing affairs are needed. 
 
At a service level, if evaluation measures used in clinical practice or research do not 
adequately highlight patient-valued domains, service provision may also fail to focus 
on complex issues, such as preparation for death, and seek to focus only on managing 
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physical symptoms, limiting the potential impact of palliative care on identified 
patient-valued outcomes.  
 
The high value placed on the ability to prepare for death and manage affairs by people 
at the end of life has been clearly demonstrated. Having ‘financial affairs in order’ 
was rated ‘important’ or ‘very important’ by 94% (320/340) of people with advanced 
chronic illness randomly selected from the national Veterans Affairs database in the 
United States (US) (2) and for 87% (349/434) of older Canadian patients with a 50% 
probability of survival for six months, ‘completing things and preparing for life’s end’ 
was ‘very’ or ‘extremely important’ (3). Therefore, quantifying the impact of 
palliative care involvement on this domain in clinical research is crucial, although few 
measurement tools administered in this setting have attempted to do this.  
 
In a recent systematic review by Zimmermann et al. (4) examining the effectiveness 
of specialized palliative care teams, only one study (8%) used a QOL measurement 
tool specific for a palliative care population. However, this tool did not explicitly 
include preparation for death (5). Similarly, the measurement tools administered in 
the remaining 11 studies, including the European Organization for Research and 
Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) (6) and the 
Medical Outcomes Study Short Form (SF-36) (7) did not explicitly include this 
domain. Research into patients’ values at the end of life has grown considerably since 
these tools were initially constructed and some of the more recent palliative care 
specific measurement tools do include preparation for death, although the focus first 
tends to be on health-related domains such as symptoms or functional status (8) (9).  
 
Research that seeks to define the relative benefits of different models of care for end 
of life, including palliative care, is used by health systems around the world, such as 
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Medicare in the US, to inform decisions regarding the funding and provision of 
palliative care services. The data needed to inform such deliberations should include 
the outcomes most valued by patients themselves. It is crucial that the impact of 
interventions on important patient-relevant domains, including preparation for death 
and managing affairs, is systematically captured. Otherwise, a sub-optimal model of 
measurement could lead to missed funding opportunities for valuable palliative care 
programs or interventions may be inappropriately supported. Once these impacts are 
captured, robust analysis of multiple patient-valued domains is available to evaluate 
complex interventions like palliative care that span in-patient, out-patient and 
community care across a large number of providers (10). 
 
It is vital that clinicians and researchers choose appropriate tools to measure important 
patient-relevant aspects of QOL, including preparation for death and managing 
affairs. Such data can drive clinical practice to ensure opportunities are optimized for 
patients and evaluation studies are better informed. There are numerous QOL and 
health-related QOL measurement tools available to assess comparative effectiveness 
and cost-effectiveness of health care interventions in clinical research. The desire to 
choose a well-established, robust tool that has been used many times before and 
produces generalisable data should not outweigh the need to systematically capture 
the impact of interventions on patient-relevant aspects in palliative care. The article 
by Borreani et al. (1) is a timely reminder that continuing development of palliative 
care specific QOL measurement tools is required, particularly given the apparent 
paucity of tools that include preparation for death and managing affairs as 
components.  
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